Title: Family Medicine – Pharmacology: New Drugs; Anticoagulants – Oral; Antimicrobial Resistance
Faculty: Vandana Y. Bhide, M.D., F.A.C.P., F.A.A.P., A.B.I.H.M, Keith S. Kaye, M.D., M.P.H., Gerald W. Smetana, M.D.
Original Release Date: July 1, 2019 Expiration Date: July 1, 2022
TOPIC 1: New Drugs for the Primary Care Physician: What You Need to Know. COMP
Upon completion of this session, the participant should be able to:
- Survey important advances in pharmacotherapy that pertain to primary care practice.
- Discuss the efficacy and list the side effects for each drug.
- Differentiate key new drugs with previously available medications for similar indications.
TOPIC 2: Novel Oral Anticoagulants.
Upon completion of this session, the participant should be able to: EBM, COMP
- Differentiate the advantages and disadvantages of commonly used anticoagulants.
- Employ evidence-based anticoagulation bridging regimens.
- Assess the approved indications for various anticoagulation agents.
- Apply the evidence-based indications for anticoagulation in hospitalized patients.
TOPIC 3: Update on Antimicrobial Resistance.
Upon completion of this session, using IDSA and SHEA evidence-based guidelines and CDC and WHO surveys, the participant should be able to: EBM, GL, COMP
- Interpret the pattern of emergence of resistance of certain infecting bacteria.
- Analyze the epidemiology that may indicate potential resistance among the organisms discussed, such as:
- Gram negative bacilli.
- Use current therapeutic regimens while considering resistance.
- The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
- This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.